|
|
|
|
|
|
|
|
|
|
AGE |
TYPE |
ANS |
|
|
63 |
3 |
9 |
|
TYPE DE RETINOPATHIE |
|
56 |
3 |
8 |
|
|
77 |
3 |
12 |
|
TOTAL |
|
71 |
4 |
24 |
|
|
N/A |
RD0 |
RDNP minime |
RDNP modérée |
RDNP sévère |
RDP |
TOTAL RD |
|
56 |
3 |
5 |
|
17 |
|
15 |
1 |
1 |
|
|
2 |
|
73 |
3 |
10 |
|
100,00% |
|
88,24% |
5,88% |
5,88% |
|
|
11,76% |
|
48 |
3 |
6 |
|
|
61 |
3 |
7 |
|
|
|
70 |
3 |
10 |
|
|
54 |
3 |
7 |
|
|
67 |
4 |
21 |
|
|
56 |
3 |
2 |
|
|
63 |
3 |
3 |
|
|
55 |
4 |
7 |
|
|
75 |
3 |
26 |
|
|
72 |
3 |
4 |
|
|
60 |
3 |
9 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL INTERPRETABLE |
|
|
|
|
|
|
RD0 |
RDNP minime |
RDNP modérée |
RDNP sévère |
RDP |
TOTAL RD |
|
|
|
|
|
|
88,24% |
5,88% |
5,88% |
|
|
11,76% |
100,00% |
|
|
|
|
|
|
15 |
1 |
1 |
|
|
2 |
17 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL OD + OG |
|
|
N/A |
RD0 |
RDNP minime |
RDNP modérée |
RDNP sévère |
RDP |
|
|
OD |
2 |
13 |
1 |
1 |
|
|
17 |
|
OG |
|
16 |
|
1 |
|
|
17 |
|
|
2 |
29 |
1 |
2 |
|
|
34 |
|
OD |
11,76% |
76,47% |
5,88% |
5,88% |
|
|
100,00% |
|
OG |
|
94,12% |
|
5,88% |
|
|
100,00% |
|
MOYENNE |
5,88% |
85,29% |
2,94% |
5,88% |
|
|
100,00% |
|
|
HOMMES |
|
|
N/A |
RD0 |
RDNP minime |
RDNP modérée |
RDNP sévère |
RDP |
|
|
OD |
2 |
7 |
1 |
|
|
|
10 |
|
OG |
|
10 |
|
|
|
|
10 |
|
|
2 |
17 |
1 |
|
|
|
20 |
|
MAX |
|
9 |
1 |
|
|
|
10 |
|
HOMMES |
|
90,00% |
10,00% |
|
|
|
100,00% |
|
OD |
20,00% |
70,00% |
10,00% |
|
|
|
100,00% |
|
OG |
|
100,00% |
|
|
|
|
100,00% |
|
MOYENNE |
10,00% |
85,00% |
5,00% |
|
|
|
100,00% |
|
|
|
FEMMES |
|
|
N/A |
RD0 |
RDNP minime |
RDNP modérée |
RDNP sévère |
RDP |
|
|
OD |
|
6 |
|
1 |
|
|
7 |
|
OG |
|
6 |
|
1 |
|
|
7 |
|
TOTAL |
|
12 |
|
2 |
|
|
14 |
|
MAX/PATIENT |
|
6 |
|
1 |
|
|
7 |
|
FEMMES |
|
85,71% |
|
14,29% |
|
|
100,00% |
|
OD |
|
85,71% |
|
14,29% |
|
|
100,00% |
|
OG |
|
85,71% |
|
14,29% |
|
|
100,00% |
|
FEMMES |
|
85,71% |
|
14,29% |
|
|
100,00% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|